$WTER
ALKALINE WATER Co INC

2021 Q4 Form 10-Q Financial Statement

#000106299322004240 Filed on February 14, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $15.11M $15.26M $9.616M
YoY Change 57.13% 50.15% 13.73%
Cost Of Revenue $10.13M $10.09M $6.264M
YoY Change 61.69% 55.03% 23.76%
Gross Profit $4.982M $5.164M $3.352M
YoY Change 48.62% 41.44% -1.22%
Gross Profit Margin 32.97% 33.85% 34.86%
Selling, General & Admin $15.91M $15.37M $7.576M
YoY Change 109.96% 81.28% 28.61%
% of Gross Profit 319.25% 297.67% 225.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $159.0K $159.0K $282.0K
YoY Change -43.6% -13.77% 10.91%
% of Gross Profit 3.19% 3.08% 8.41%
Operating Expenses $15.91M $15.37M $7.576M
YoY Change 109.96% 77.51% 23.29%
Operating Profit -$10.92M -$10.21M -$4.223M
YoY Change 158.65% 141.29% 53.53%
Interest Expense $142.9K -$170.2K $136.9K
YoY Change 4.37% 30.92% 23.57%
% of Operating Profit
Other Income/Expense, Net $187.7K -$170.2K -$136.9K
YoY Change -237.06% 29.99% 23.57%
Pretax Income -$10.74M -$10.38M -$4.360M
YoY Change 146.24% 138.04% 52.45%
Income Tax
% Of Pretax Income
Net Earnings -$10.74M -$10.38M -$4.360M
YoY Change 146.22% 137.95% 52.37%
Net Earnings / Revenue -71.05% -68.03% -45.34%
Basic Earnings Per Share -$0.10 -$0.11
Diluted Earnings Per Share -$101.7K -$110.8K -$59.30K
COMMON SHARES
Basic Shares Outstanding 105.6M shares 93.67M shares 73.53M shares
Diluted Shares Outstanding 105.6M shares 93.67M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.293M $10.42M $1.720M
YoY Change 91.47% 161.79% -58.75%
Cash & Equivalents $3.293M $10.42M $1.717M
Short-Term Investments
Other Short-Term Assets $2.430M $2.947M $1.550M
YoY Change 56.77% 12.46% -25.12%
Inventory $8.830M $6.278M $4.110M
Prepaid Expenses
Receivables $7.773M $10.98M $4.890M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $22.33M $30.63M $12.27M
YoY Change 81.96% 84.17% 3.1%
LONG-TERM ASSETS
Property, Plant & Equipment $1.170M $1.198M $1.190M
YoY Change -1.67% 6.96% -18.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.170M $1.198M $1.200M
YoY Change -2.49% 6.63% -17.91%
TOTAL ASSETS
Total Short-Term Assets $22.33M $30.63M $12.27M
Total Long-Term Assets $1.170M $1.198M $1.200M
Total Assets $23.50M $31.82M $13.47M
YoY Change 74.43% 79.26% 0.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.389M $7.985M $5.000M
YoY Change 47.78% 51.67% 1.05%
Accrued Expenses $1.572M $1.595M $1.990M
YoY Change -21.02% 5.49% 99.16%
Deferred Revenue
YoY Change
Short-Term Debt $6.427M $6.998M $4.000M
YoY Change 60.67% 45.79% 37.93%
Long-Term Debt Due $0.00 $330.6K $240.0K
YoY Change -100.0% 50.25%
Total Short-Term Liabilities $15.39M $16.91M $11.22M
YoY Change 37.14% 41.92% 25.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $90.00K
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $175.0K $193.8K $330.0K
YoY Change -46.96% 869.0%
Total Long-Term Liabilities $175.0K $193.8K $420.0K
YoY Change -58.32% 49.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.39M $16.91M $11.22M
Total Long-Term Liabilities $175.0K $193.8K $420.0K
Total Liabilities $15.56M $17.10M $11.65M
YoY Change 33.58% 41.95% 30.62%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $73.64K
YoY Change 68.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.934M $14.72M $1.820M
YoY Change
Total Liabilities & Shareholders Equity $23.50M $31.82M $13.47M
YoY Change 74.43% 79.26% 0.8%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income -$10.74M -$10.38M -$4.360M
YoY Change 146.22% 137.95% 52.37%
Depreciation, Depletion And Amortization $159.0K $159.0K $282.0K
YoY Change -43.6% -13.77% 10.91%
Cash From Operating Activities -$7.210M -$12.68M -$1.490M
YoY Change 383.88% 89.18% -3.87%
INVESTING ACTIVITIES
Capital Expenditures -$177.9K -$254.0K -$60.00K
YoY Change 196.53% 1169.85% 100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$177.9K -$254.0K -$60.00K
YoY Change 196.53% 1169.85% 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 262.0K 18.85M -710.0K
YoY Change -136.9% 270.34% -36.61%
NET CHANGE
Cash From Operating Activities -7.210M -12.68M -1.490M
Cash From Investing Activities -177.9K -254.0K -60.00K
Cash From Financing Activities 262.0K 18.85M -710.0K
Net Change In Cash -7.126M 5.921M -2.260M
YoY Change 215.3% -463.26% -16.3%
FREE CASH FLOW
Cash From Operating Activities -$7.210M -$12.68M -$1.490M
Capital Expenditures -$177.9K -$254.0K -$60.00K
Free Cash Flow -$7.032M -$12.42M -$1.430M
YoY Change 391.74% 85.95% -5.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107242070 shares
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Revenues
Revenues
15110400 USD
CY2020Q4 us-gaap Revenues
Revenues
9616200 USD
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10128144 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6263961 USD
CY2021Q4 us-gaap Gross Profit
GrossProfit
4982256 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
3352239 USD
CY2021Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9572279 USD
CY2020Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4091435 USD
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3484221 USD
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
15905942 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
7575656 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-10923686 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4223417 USD
CY2021Q4 us-gaap Interest Expense
InterestExpense
142898 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
136917 USD
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
187653 USD
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6333663 USD
CY2021Q4 wter Gain On Forgiveness Of Ppp Loan Payable
GainOnForgivenessOfPppLoanPayable
330551 USD
CY2020Q4 wter Gain On Forgiveness Of Ppp Loan Payable
GainOnForgivenessOfPppLoanPayable
0 USD
wter Gain On Forgiveness Of Ppp Loan Payable
GainOnForgivenessOfPppLoanPayable
330551 USD
wter Gain On Forgiveness Of Ppp Loan Payable
GainOnForgivenessOfPppLoanPayable
0 USD
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-136917 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2900000 USD
CY2020Q2 wter Stock Issued During Period Warrant Exercises
StockIssuedDuringPeriodWarrantExercises
258900 USD
CY2020Q2 wter Common Shares Issued To Nonemployees And Employees
CommonSharesIssuedToNonemployeesAndEmployees
487300 USD
CY2020Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
661959 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
61480 USD
CY2020Q2 wter Stock Payable During Period
StockPayableDuringPeriod
1999998 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-3021003 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
4970767 USD
CY2020Q3 wter Stock Issued During Period Warrant Exercises
StockIssuedDuringPeriodWarrantExercises
4564323 USD
CY2020Q3 wter Common Shares Issued To Non Employees
CommonSharesIssuedToNonEmployees
326599 USD
CY2020Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
204594 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4361628 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5704655 USD
CY2020Q4 wter Stock Issued During Period Warrant Exercises
StockIssuedDuringPeriodWarrantExercises
91665 USD
CY2020Q4 wter Common Shares Issued To Non Employees
CommonSharesIssuedToNonEmployees
119999 USD
CY2020Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
50000 USD
CY2020Q4 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
213698 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-4360334 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1819683 USD
CY2021Q3 wter Stock Issued During Period Warrant Exercises
StockIssuedDuringPeriodWarrantExercises
11904220 USD
CY2021Q3 wter Common Shares Issued To Non Employees
CommonSharesIssuedToNonEmployees
307719 USD
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
625556 USD
us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
30000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-10736033 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-4360334 USD
CY2021Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105580951 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73528255 shares
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
59950 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-10378473 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
14722269 USD
CY2021Q4 wter Stock Issued During Period Warrant Exercises
StockIssuedDuringPeriodWarrantExercises
833316 USD
CY2021Q4 wter Common Shares Issued To Non Employees
CommonSharesIssuedToNonEmployees
20700 USD
CY2021Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
3093350 USD
us-gaap Stock Issued1
StockIssued1
0 USD
us-gaap Stock Issued1
StockIssued1
1000000 USD
wter Non Cash Lease Expense
NonCashLeaseExpense
9624 USD
wter Non Cash Lease Expense
NonCashLeaseExpense
932 USD
us-gaap Selling Expense
SellingExpense
11824231 USD
us-gaap Selling Expense
SellingExpense
5315518 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <div> <div> <div style="text-align: justify;"> <p style="margin: 0pt 0pt 13px;"><span style="text-decoration-line: underline; font-family: Times New Roman, Times, serif; font-size: 10pt;">Concentration Risks</span></p> </div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">We have 2 major customers that together account for 32% (17% and 15%, respectively) of accounts receivable at December 31, 2021, 2 customer that accounts for 34% (17% and 17%, respectively) of total revenues for the three months ended December 31, 2021 and 2 customers that accounts for 33% (19% and 14%, respectively) of the total revenues earned for the nine months ended December 31, 2021. The Company has 3 vendors that accounts for 52% (27%, 14% and 11% respectively) of purchases for the three months ended December 31, 2021 and 3 vendors that accounted for 49% (25%, 14% and 10% respectively) of purchases for the nine months ended December 31, 2021.</span></span></p> </div> </div> <div> <div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">We have 2 major customers that together account for 35% (18% and 17%, respectively) of accounts receivable at December 31, 2020, 2 customer that accounts for 40% (25% and 15%, respectively) of total revenues for the three months ended December 31, 2020 and 2 customers that accounts for 40% (23% and 17%, respectively) of the total revenues earned for the nine months ended December 31, 2020. The Company has 2 vendors that accounts for 48% (24% and 24% respectively) of purchases for the three months ended December 31, 2020 and 3 vendors that accounted for 53% (23%, 19% and 11% respectively) of purchases for the nine months ended December 31, 2020.</span></span></p> </div> </div> </div>
us-gaap Depreciation
Depreciation
477045 USD
us-gaap Depreciation
Depreciation
694279 USD
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
556758 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2484687 USD
CY2020Q4 wter Depreciation Expense Reclassified
DepreciationExpenseReclassified
278751 USD
wter Depreciation Expense Reclassified
DepreciationExpenseReclassified
686372 USD
CY2020Q4 wter Sales And Marketing Expenses Reclassified
SalesAndMarketingExpensesReclassified
563495 USD
wter Sales And Marketing Expenses Reclassified
SalesAndMarketingExpensesReclassified
1946003 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6263961 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21368066 USD
CY2020Q4 us-gaap Revenues
Revenues
9616200 USD
us-gaap Revenues
Revenues
33209062 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
3352239 USD
us-gaap Gross Profit
GrossProfit
11840996 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
158440 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6426601 USD
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4324412 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
129000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
129000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.64
CY2021Q4 wter Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
666667 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.25
CY2021Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
833334 USD
CY2021Q4 wter Operating Lease Right Of Use Asset Current
OperatingLeaseRightOfUseAssetCurrent
167299 USD
CY2021Q4 wter Operating Lease Right Of Use Asset Non Current
OperatingLeaseRightOfUseAssetNonCurrent
143693 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
47288 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
119150 USD

Files In Submission

Name View Source Status
0001062993-22-004240-index-headers.html Edgar Link pending
0001062993-22-004240-index.html Edgar Link pending
0001062993-22-004240.txt Edgar Link pending
0001062993-22-004240-xbrl.zip Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
form10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wter-20211231.xsd Edgar Link pending
wter-20211231_cal.xml Edgar Link unprocessable
wter-20211231_def.xml Edgar Link unprocessable
wter-20211231_lab.xml Edgar Link unprocessable
wter-20211231_pre.xml Edgar Link unprocessable